JobsCelcuity Inc.
Celcuity Inc. logo

Celcuity Inc.

Biotechnology
236 employeesMinneapolis, MN

About Celcuity Inc.

Targeted therapies only work when inhibiting the target pathway disrupts the oncogenic process. Celcuity鈥檚 platform provides unparalleled insights into oncogenic pathways. We harness these insights to develop new targeted therapies for cancer patients. Our lead candidate is gedatolisib, a pan-PI3K, mTORC1/2 inhibitor that comprehensively blockades the PI3K/AKT/mTOR (PAM) pathway.

Open roles (10)

US roles only: 0 路 All: 10

Company details

Employees
236
Industry
Biotechnology
Headquarters
Minneapolis, MN

Key people

Fred Kerwood
Fred Kerwood
LinkedIn
Naomi Gutierrez
Naomi Gutierrez
LinkedIn
Nadene Zack, MS
Nadene Zack, MS
LinkedIn
David Elks
David Elks
LinkedIn